JP2022545802A5 - - Google Patents

Info

Publication number
JP2022545802A5
JP2022545802A5 JP2022511279A JP2022511279A JP2022545802A5 JP 2022545802 A5 JP2022545802 A5 JP 2022545802A5 JP 2022511279 A JP2022511279 A JP 2022511279A JP 2022511279 A JP2022511279 A JP 2022511279A JP 2022545802 A5 JP2022545802 A5 JP 2022545802A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
pharmaceutical product
independently
product according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022511279A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022545802A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/047451 external-priority patent/WO2021035157A1/en
Publication of JP2022545802A publication Critical patent/JP2022545802A/ja
Publication of JP2022545802A5 publication Critical patent/JP2022545802A5/ja
Pending legal-status Critical Current

Links

JP2022511279A 2019-08-22 2020-08-21 有機化合物 Pending JP2022545802A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962890162P 2019-08-22 2019-08-22
US62/890,162 2019-08-22
PCT/US2020/047451 WO2021035157A1 (en) 2019-08-22 2020-08-21 Organic compounds

Publications (2)

Publication Number Publication Date
JP2022545802A JP2022545802A (ja) 2022-10-31
JP2022545802A5 true JP2022545802A5 (https=) 2023-08-10

Family

ID=74659635

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022511279A Pending JP2022545802A (ja) 2019-08-22 2020-08-21 有機化合物

Country Status (4)

Country Link
US (1) US20220280517A1 (https=)
EP (1) EP4017858A4 (https=)
JP (1) JP2022545802A (https=)
WO (1) WO2021035157A1 (https=)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8133903B2 (en) * 2003-10-21 2012-03-13 Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases
WO2012070040A1 (en) * 2010-11-26 2012-05-31 Technion Research And Development Foundation Ltd Compositions and methods for ameliorating renal dysfunction induced by renal hypoperfusion or acute kidney injury
CA2877146C (en) * 2012-06-18 2020-10-20 Dart Neuroscience (Cayman) Ltd Substituted thiophene- and furan-fused azolopyrimidine-5-(6h)-one compounds
US10285992B2 (en) * 2014-08-07 2019-05-14 Intra-Cellular Therapies, Inc. Combinations of PDE1 inhibitors and NEP inhibitors and associated methods
US10131671B2 (en) * 2014-08-07 2018-11-20 Intra-Cellular Therapies, Inc. Organic compounds
TWI609870B (zh) * 2016-02-12 2018-01-01 美國禮來大藥廠 Pde1抑制劑
JOP20170164A1 (ar) * 2016-08-25 2019-01-30 Lilly Co Eli مشتق ترايازولو بيرازينون مفيد كمثبط لـ pde1 بشري
JP7401442B2 (ja) * 2018-01-31 2023-12-19 イントラ－セルラー・セラピーズ・インコーポレイテッド 新規使用
US11453673B2 (en) * 2018-02-06 2022-09-27 Eli Lilly And Company Substituted [1,2,4]triazolo[4,3-a]pyrazines as phosphodiesterase inhibitors
WO2022026417A1 (en) * 2020-07-26 2022-02-03 Intra-Cellular Therapies, Inc. Novel uses
MX2023008755A (es) * 2021-01-27 2023-08-02 Intra Cellular Therapies Inc Cristales de sal.

Similar Documents

Publication Publication Date Title
JP2024504932A5 (https=)
RU2002107203A (ru) Производные N-гетероциклических соединений в качестве ингибиторов синтазы оксида азота (nos)
RU2005137403A (ru) Новые замещенные 3-сера-индолы
RU2440330C2 (ru) ПРОИЗВОДНЫЕ 4-(2-АМИНО-1-ГИДРОКСИЭТИЛ)ФЕНОЛА, КАК АГОНИСТЫ β2 АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА
RU2403251C2 (ru) Производные 2, 4-ди(гетеро)ариламинопиримидина в качестве ингибиторов zap-70
JP2005539045A5 (https=)
JP2007502264A5 (https=)
RU2004135064A (ru) Новые замещенные индолы
JP2021514001A5 (https=)
JP2003313141A (ja) ｈＰＰＡＲδアゴニストの医薬的使用
CZ289033B6 (cs) Sirné deriváty azetidinonových sloučenin, farmaceutický preparát je obsahující a způsob jeho přípravy a kit
JP2004534035A5 (https=)
JP2003517035A5 (https=)
JPH09188669A (ja) ３−トリフェニルメチルチアゾリジン−２，４−ジオン誘導体
WO2005030193A1 (en) 4-(phenyl-ethylideneaminoxy-propoxy) -phenyl-acetic acid derivatives and related compounds as pai-1 inhibitors for the treatment of impairment of the fibrinolytic system and of thrombosis
KR920021541A (ko) 벤조푸란 유도체
RU2394028C2 (ru) Производные бензилтриазолона в качестве ненуклеозидных ингибиторов обратной транскриптазы
RU96113098A (ru) Производные 5,6-дигидропирона в качестве ингибитора протеазы и антивирусные средства
JP2017507915A5 (https=)
JP2023550444A5 (https=)
JP2018526448A (ja) 一酸化窒素を放出可能なプロドラッグ分子
JP2025512995A5 (https=)
RU2008119994A (ru) Ингибиторы калиевых каналов
JP2024523488A5 (https=)
JP2022546711A5 (https=)